drugset / Trial / NCT04657926

A Trial of APPA in the Treatment of Knee Osteoarthritis

NCT04657926

Phase 2 Completed 152 enrolled AKL Research and Development NBCD A/S · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A placebo controlled study of APPA in 150 participants with Osteoarthritis of the knee

Timeline

Start
2020-09-09
Primary completion
2021-09-30
Completion
2021-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 2-hydroxy-4-methoxyacetophenone Unknown Oral
Subject Apocynin Small molecule Oral

Indications